2016


To access this material please log in or register

Register Authorize
2016/№4

Primary microvascular angina (cardiac syndrome X). Controversial and open issues: terms, definitions, pathogenetic mechanisms

Boldueva S. A., Leonova I. A.
State Budgetary Educational Institution of Higher Professional Education, “I. I. Mechnikov North-West State Medical University” of the RF Ministry of Health Care, Kirochnaya 41, St.-Petersburg 191015

Keywords: IHD, cardiac syndrome X, microvascular angina, endothelial dysfunction, pathogenesis

DOI: 10.18087/rhj.2016.4.2196

Primary microvascular angina or cardiac syndrome X, as this condition is still called, is a cardiology issue, which still contains many gaps. The unsolved questions concern different ideas about pathogenetic mechanisms of this disease, its clinical forms, and diagnostic criteria, which eventually results in either overdiagnosis of the disease or underestimation of its clinical significance. The review discusses terminology, classification, and pathogenetic mechanisms of this disease because it is impossible to treat a disease adequately and to influence the prognosis without understanding the pathogenesis of disease.
  1. Vermeltfoort IA, Raijmakers PG, Riphagen II, Odekerken DA, Kuijper AF, Zwijnenburg A, Teule GJ. Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol. 2010 Aug;99 (8);475–81.
  2. Cannon RO, Epstein SE. «Microvascular angina» as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988 Jun 1;61 (15):1338–48.
  3. Jones E, Eteiba W, Merz NB. Cardiac syndrome X and microvascular coronary dysfunction. Trends Cardiovasc Med. 2012 Aug;22 (6):161–8.
  4. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 1973 Sep 7;32 (3):375–6.
  5. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013 Oct;34 (38):2949–3003.
  6. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology and management. Circulation. 2010 Jun 1;121 (21):2317–25.
  7. Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007 Feb;93 (2):159–66.
  8. Юсупова А. О., Щендрыгина А. А., Привалова Е. В., Беленков Ю. Н. Микроваскулярная стенокардия. Кардиология. 2014;54 (4):51–9 [Yusupova A. O., Shhendry`gina A. A., Privalova E. V., Belenkov Yu. N. Mikrovaskulyarnaya stenokardiya. Kardiologiya. 2014;54 (4):51–9].
  9. Kothawade K, Bairey Merz CN. Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol. 2011 Aug;36 (8):291–318.
  10. Алексеева О. П., Долбин И. В., Федоренко А. А. Кардиальный синдром Х (особенности патогенеза и лечения). – Нижний Новгород: НГМА, 2007. – 118с [Alekseeva O. P., Dolbin I. V., Fedorenko A. A. Kardial`ny`j sindrom X (osobennosti patogeneza i lecheniya). – Nizhnij Novgorod: NGMA, 2007. – 118s].
  11. Humphries КН, Pu А, Gao М, Carere RG, Pilote L. Angina with «normal» coronary arteries: sex differences in outcomes. Am Heart J. 2008 Feb;155 (2):375–81 [Humphries KN, Pu A, Gao M, Carere RG, Pilote L. Angina with «normal» coronary arteries: sex differences in outcomes. Am Heart J. 2008 Feb;155 (2):375–81].
  12. Лупанов В. П., Доценко Ю. В. Диагностика и лечение больных с кардиальным синдромом Х. Русский медицинский журнал. 2009;17 (14):903–9 [Lupanov V. P., Doczenko Yu. V. Diagnostika i lechenie bol`ny`x s kardial`ny`m sindromom X. Russkij mediczinskij zhurnal. 2009;17 (14):903–9].
  13. Колесниченко М. Г., Болдуева С. А., Леонова И. А., Рыжкова Д. В., Нестеренко А. О., Липунова А. С., Захарова О. В. Критерии диагностики и распространенность кардиального синдрома Х по данным трех стационаров Санкт-Петербурга. CardioСоматика. 2012;3:5–11 [Kolesnichenko M. G., Boldueva S. A., Leonova I. A., Ry`zhkova D. V., Nesterenko A. O., Lipunova A. S., Zaxarova O. V. Kriterii diagnostiki i rasprostranennost` kardial`nogo sindroma X po danny`m trex staczionarov Sankt-Peterburga. CardioSomatika. 2012;3:5–11].
  14. Suzuki H. Different definition of microvascular angina. Eur J Clin Invest. 2015 Dec;45 (12):1360–6.
  15. Chauhan A, Mullins PA, Thuraisingham SI, Petch MC, Schofield PM. Clinical presentation and functional prognosis in syndrome X. Br Heart J. 1993;70 (4):346–51.
  16. Телкова И. Л., Внушинская М. А. Отдаленные клинические исходы коронарного синдрома Х по данным 15‑летнего мониторинга. Клиническая медицина. 2010;88 (1):18–22 [Telkova I. L., Vnushinskaya M. A. Otdalenny`e klinicheskie isxody` koronarnogo sindroma X po danny`m 15‑letnego monitoringa. Klinicheskaya mediczina. 2010;88 (1):18–22].
  17. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012 Nov;33 (22):2771–82.
  18. Bugiardini R, Bairey Merz CN. Angina with «normal» coronary arteries: a changing philosophy. JAMA. 2005 Jan 26;293 (4):477–84.
  19. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009 May 11;169 (9):843–50.
  20. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014 May;35 (17):1101–11.
  21. Cotrim C, Almeida AG, Carrageta M. Cardiac syndrome X, intraventricular gradients and, beta-blockers. Rev Port Cardiol. 2010 Feb;29 (2):193–203.
  22. Cannon RO III. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol. 2009 Sep 1;54 (10):877–85.
  23. Kim BS, Kim HJ, Han SW, Kim SH, Suh SY, Chung SM, Ryu KH. Slow coronary flow is related to increased carotid intima-media thickness but not pulse wave velocity. Korean Circ J. 2011 Nov;41 (11):666–70.
  24. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991 Feb;17 (2):499–506.
  25. Campisi R. Noninvasive assessment of coronary microvascular function in women at risk for ischemic heart disease. Int J Clin Pract. 2008 Feb;62 (2):300–7.
  26. Kuruvilla S, Kramer CM. Coronary microvascular dysfunction in women: an overview of diagnostic strategies. Expert Rev Cardiovasc Ther. 2013 Nov;11 (11):1515–25.
  27. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation. 2004 Feb 10;109 (5):568–72.
  28. Yamamoto S, James TN, Kawamura K, Nobuyoshi M. Cardiocytic apoptosis and capillary endothelial swelling as morphological evidence of myocardial ischemia in ventricular biopsies from patients with angina and normal coronary arteriograms. Coron Artery Dis. 2002 Feb;13 (1):25–35.
  29. Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol. 1994 Feb;43 (2):139–50.
  30. Zorc-Pleskovič R, Vraspir-Porenta O, Zorc M, Milutinovic A, Petrovic D. Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein. Folia Biol (Praha). 2008;54 (1):30–2.
  31. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, Takeshita A. Angina pectoris caused by coronary microvascular spasm. Lancet. 1998 Apr 18;351 (9110):1165–9.
  32. Ong P, Athanasiadis А, Mahrholdt H, Borgulya G, Sechtem U, Kaski JC. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol. 2012 Aug;101 (8):673–81 [Ong P, Athanasiadis A, Mahrholdt H, Borgulya G, Sechtem U, Kaski JC. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol. 2012 Aug;101 (8):673–81].
  33. Sanderson JE, Woo KS, Chung HK, Chan WM, Tse KK, White HD. Endothelium-dependent dilation of the coronary arteries in syndrome X: effects of the cold pressor test. Cardiology. 1997 Sep-Oct;88 (5):414–7.
  34. Рыжкова Д. В., Колесниченко М. Г., Болдуева С. А., Костина И. С. Изучение состояния коронарной гемодинамики методом позитронной эмиссионной томографии у пациентов с кардиальным синдромом Х. Сибирский медицинский журнал (г. Томск). 2012;27 (2):50–6 [Ry`zhkova D. V., Kolesnichenko M. G., Boldueva S. A., Kostina I. S. Izuchenie sostoyaniya koronarnoj gemodinamiki metodom pozitronnoj e`missionnoj tomografii u paczientov s kardial`ny`m sindromom X. Sibirskij mediczinskij zhurnal (g. Tomsk). 2012;27 (2):50–6].
  35. Ohba К, Sugiyama S, Sumida H, Nozaki T, Matsubara J, Matsuzawa Y et al. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J Am Heart Assoc. 2012 Oct;1 (5):e002485 [Ohba K, Sugiyama S, Sumida H, Nozaki T, Matsubara J, Matsuzawa Y et al. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J Am Heart Assoc. 2012 Oct;1 (5):e002485].
  36. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol. 2002 Mar 6;39 (5):847–51.
  37. Radico F, Cicchitti V, Zimarino M, De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv. 2014 May;7 (5):453–63.
  38. Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A et al. Ischemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res. 2011 Apr 1;90 (1):9–17.
  39. Липунова А. С., Болдуева С. А., Леонова И. А. соавт. Роль дисфункции эндотелия в генезе кардиального синдрома Х. Профилактическая и клиническая медицина. 2013;1 (46):38–42 [Lipunova A. S., Boldueva S. A., Leonova I. A. soavt. Rol` disfunkczii e`ndoteliya v geneze kardial`nogo sindroma X. Profilakticheskaya i klinicheskaya mediczina. 2013;1 (46):38–42].
  40. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004 Jun 1;109 (21):2518–23.
  41. Петрова В. Б., Болдуева С. А., Петрова А. Б. Перцепция боли и уровень эндотелина-1 у пациентов с кардиальным синдромом Х. Российский кардиологический журнал. 2014;5 (Прил 1):94 [Petrova V. B., Boldueva S. A., Petrova A. B. Perczepcziya boli i uroven` e`ndotelina-1 u paczientov s kardial`ny`m sindromom X. Rossijskij kardiologicheskij zhurnal. 2014;5 (Pril 1):94].
  42. Desideri G, Gaspardone A, Gentile M, Santucci A, Gioffri PA, Ferri C. Endothelial activation in patients with cardiac syndrome X. Circulation. 2000 Nov 7;102 (19):2359–64.
  43. Shmilovich H, Deutsch V, Roth A, Miller H, Keren G, George J. Circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart. 2007 Sep;93 (9):1071–6.
  44. Celik A, Balin M, Kobat MA, Erdem K, Baydas A, Bulut M et al. Deficiency of a new protein associated with cardiac syndrome X; called adropin. Cardiovasc Ther. 2013 Jun;31 (3):174–8.
  45. Gil-Ortega I, Marzoa Rivas R, Ríos Vázquez R, Kaski JC. Role of inflammation and endothelial dysfunction in the pathogenesis of cardiac syndrome X. Future Cardiol. 2006 Jan;2 (1):63–73.
  46. Clausell N, Prado KF, Ribeiro JP. Increased plasma levels of soluble vascular cellular adhesion molecule-1 in patients with chest pain and angiographically normal coronary arteries. Int J Cardiol. 1999 Mar 15;68 (3):275–80.
  47. Recio-Mayoral A, Rimoldi OE, Camici PG, Kaski JC. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging. 2013 Jun;6 (6):660–7.
  48. Teragawa H, Fukuda Y, Matsuda K, Ueda K, Higashi Y, Oshima T et al. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart. 2004 Jul;90 (7):750–4.
  49. Madaric J, Bartunek J, Verhamme K, Penicka M, Van Schuerbeeck E, Nellens P et al. Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries. J Am Coll Cardiol. 2005 Oct 4;46 (7):1270–5.
  50. Gulli G, Cemin R, Pancera P, Menegatti G, Vassanelli C, Cevese A. Evidence of parasympathetic impairment in some patients with cardiac syndrome X. Cardiovasc Res. 2001 Nov;52 (2):208–16.
  51. Шевченко Ю. Л., Тыренко В. В., Никитин А. Е. Исследование адренергической иннервации у больных с кардиальным синдромом Х. Клиническая медицина. 2001;79 (10):14–7 [Shevchenko Yu. L., Ty`renko V. V., Nikitin A. E. Issledovanie adrenergicheskoj innervaczii u bol`ny`x s kardial`ny`m sindromom X. Klinicheskaya mediczina. 2001;79 (10):14–7].
  52. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart. 2002 Jun;87 (6):513–9.
  53. Лавинская Н. Н., Шанин В. Ю., Козлов К. Л. Оценка психо-эмоционального статуса больных с кардиальным синдромом Х. Кардиология 2003. – М.: Авиаиздат, 2003. – С. 103 [Lavinskaya N. N., Shanin V. Yu., Kozlov K. L. Oczenka psixo-e`moczional`nogo statusa bol`ny`x s kardial`ny`m sindromom X. Kardiologiya 2003. – M.: Aviaizdat, 2003. – S. 103].
  54. Тыренко В. В., Свистов А. С., Белевитин А. Б. Актуальные вопросы лечения кардиального синдрома Х. – СПб.: ВМедА, 2003. – 47с [Ty`renko V. V., Svistov A. S., Belevitin A. B. Aktual`ny`e voprosy` lecheniya kardial`nogo sindroma X. – SPb.: VMedA, 2003. – 47s].
  55. Петрова В. Б., Болдуева С. А., Леонова И. А., Липунова А. С., Феоктистова В. С., Колесниченко М. Г., Захарова О. В. Особенности болевого синдрома и психологического статуса у больных кардиальным синдромом Х. Профилактическая и клиническая медицина. 2013;4 (49):52–8 [Petrova V. B., Boldueva S. A., Leonova I. A., Lipunova A. S., Feoktistova V. S., Kolesnichenko M. G., Zaxarova O. V. Osobennosti bolevogo sindroma i psixologicheskogo statusa u bol`ny`x kardial`ny`m sindromom X. Profilakticheskaya i klinicheskaya mediczina. 2013;4 (49):52–8].
  56. Lanza GA, Sestito A, Iacovella S, Morlacchi L, Romagnoli E, Schiavoni G et al. Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina. Circulation. 2003 Mar 18;107 (10):1378–82.
  57. Чуршин А. Д. Состояние коронарных артерий, структурно-геометрические параметры сердца и функция эндотелия у женщин со стабильной ишемической болезнью сердца. Проблемы экспертизы в медицине. 2006;6 (3):65–7 [Churshin A. D. Sostoyanie koronarny`x arterij, strukturno-geometricheskie parametry` serdcza i funkcziya e`ndoteliya u zhenshhin so stabil`noj ishemicheskoj bolezn`yu serdcza. Problemy` e`kspertizy` v mediczine. 2006;6 (3):65–7].
  58. Pasqui AL, Puccetti L, Di Renzo M, Bruni F, Camarri A, Palazzuoli A et al. Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Nutr Metab Cardiovasc Dis. 2005 Feb;15 (1):56–64.
  59. Алексеева О. П., Долбин И. В. Кардиальный синдром Х: особенности патогенеза, клиники и лечения. Клиническая медицина. 2009;87 (12) 65–69 [Alekseeva O. P., Dolbin I. V. Kardial`ny`j sindrom X: osobennosti patogeneza, kliniki i lecheniya. Klinicheskaya mediczina. 2009;87 (12) 65–69].
  60. Константинова Е. Э., Цапаева Н. Л., Милютина Д. А., Миронова Е. В., Иванова Л. А. Характеристика агрегационной способности эритроцитов при артериальной гипертензии и ишемической болезни сердца. Кардиоваскулярная терапия и профилактика. 2008;7 (6):186–187 [Konstantinova E. E`., Czapaeva N. L., Milyutina D. A., Mironova E. V., Ivanova L. A. Xarakteristika agregaczionnoj sposobnosti e`ritroczitov pri arterial`noj gipertenzii i ishemicheskoj bolezni serdcza. Kardiovaskulyarnaya terapiya i profilaktika. 2008;7 (6):186–187].
  61. Siminiak T, Smielecki J, Rzezniczak J, Kazmierczak M, Kalawski R, Wysocki H. The effects of dipyridamole stress test on plasma levels of soluble adhesion molecules intracellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin and L-selectin in patients with ischemic heart disease and patients with syndrome X. Coron Artery Dis. 1999 Jun;10 (4):235–40.
  62. Петрова В. Б., Болдуева С. А., Петрова А. Б., Захарова О. В., Ефимов Н. В., Александров Н. Ю. Оценка болевой чувствительности у больных с кардиальным синдромом Х методом определения ноцицептивного флексорного рефлекса. Проблемы женского здоровья. 2014;9 (4):24–30 [Petrova V. B., Boldueva S. A., Petrova A. B., Zaxarova O. V., Efimov N. V., Aleksandrov N. Yu. Oczenka bolevoj chuvstvitel`nosti u bol`ny`x s kardial`ny`m sindromom X metodom opredeleniya nocziczeptivnogo fleksornogo refleksa. Problemy` zhenskogo zdorov`ya. 2014;9 (4):24–30].
  63. Shapiro LM, Crake T, Poole-Wilson PA. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arte­ries? Clinical observations during cardiac catheterization. Br Med J (Clin Res Ed). 1988 Jan 16;296 (6616):170–1.
  64. Skljarevski V, Ramadan NM. The nociceptive flexion reflex in humans – review article. Pain. 2002 Mar;96 (1-2):3–8.
  65. Rhudy JL, France CR. Reliability and validity of a brief method to assess nociceptive flexion reflex (NFR) threshold. J Pain. 2011 Jul;12 (7):782–91.
  66. Di Monaco A, Bruno I, Calcagni ML, Nerla R, Lamendola P, Barone L et al. Cardiac adrenergic nerve function in patients with cardiac syndrome X. J Cardiovasc Med (Hagerstown). 2010 Mar;11 (3):151–6.
  67. Соболева Г. Н., Горельцева С. Ю., Федорова В. И., Пухальская Т. Г., Погорелова О. А., Дробкова Н. В. и др. Серотонин, психовегетативный статус, перфузия миокарда и функциональное состояние эндотелия при кардиальном синдроме Х. Кардиологический вестник. 2007; II (1):26–32 [Soboleva G. N., Gorel`czeva S. Yu., Fedorova V. I., Puxal`skaya T. G., Pogorelova O. A., Drobkova N. V. i dr. Serotonin, psixovegetativny`j status, perfuziya miokarda i funkczional`noe sostoyanie e`ndoteliya pri kardial`nom sindrome X. Kardiologicheskij vestnik. 2007; II (1):26–32].
  68. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002 Jun 20;346 (25):1948–53.
  69. Azemi T, Rai M, Parwani P, Baghdasarian S, Kazi F, Ahlberg AW et al. Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: does it affect diagnosis or prognosis? J Nucl Cardiol. 2012 Feb;19 (1):84–91.
  70. Lee CW, Ho IK. Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors. Mol Pain. 2013 Sep 8;9:45.
Boldueva S. A., Leonova I. A.Primary microvascular angina (cardiac syndrome X). Controversial and open issues: terms, definitions, pathogenetic mechanisms. Russian Heart Journal. 2016;15 (4):223–234

To access this material please log in or register

Register Authorize
Ru En